- Report
- January 2022
- 60 Pages
Global
From €3485EUR$3,950USD£3,014GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3309EUR$3,750USD£2,862GBP
- Report
- July 2024
- 150 Pages
Global
From €3309EUR$3,750USD£2,862GBP
- Report
- March 2024
- 200 Pages
Global
From €3662EUR$4,150USD£3,167GBP
- Report
- January 2024
- 200 Pages
Global
From €3662EUR$4,150USD£3,167GBP
- Report
- January 2024
- 200 Pages
Global
From €3662EUR$4,150USD£3,167GBP
- Report
- August 2023
- 145 Pages
Global
From €2780EUR$3,150USD£2,404GBP
- Report
- July 2024
- 100 Pages
Global
From €3309EUR$3,750USD£2,862GBP
- Report
- June 2024
- 200 Pages
Global
From €7015EUR$7,950USD£6,067GBP
- Report
- June 2024
- 200 Pages
Global
From €7015EUR$7,950USD£6,067GBP
- Report
- June 2024
- 200 Pages
Global
From €7015EUR$7,950USD£6,067GBP
- Report
- March 2024
- 303 Pages
Global
From €7015EUR$7,950USD£6,067GBP
From €3088EUR$3,500USD£2,671GBP
- Report
- September 2024
- 88 Pages
Japan
From €3088EUR$3,500USD£2,671GBP
- Report
- February 2024
- 185 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- April 2023
- 125 Pages
Global
From €4191EUR$4,750USD£3,625GBP
- Report
- April 2023
- 117 Pages
North America
From €4191EUR$4,750USD£3,625GBP
- Report
- April 2023
- 70 Pages
Canada
From €4191EUR$4,750USD£3,625GBP
- Report
- April 2023
- 85 Pages
Europe
From €4191EUR$4,750USD£3,625GBP
- Report
- February 2024
- 120 Pages
Global
From €4191EUR$4,750USD£3,625GBP

The Dry Eye Drug market is a subset of the Optical Disorders Drugs market, which includes drugs used to treat a variety of eye conditions. Dry Eye Drugs are used to treat the symptoms of dry eye syndrome, a condition in which the eyes do not produce enough tears or the tears evaporate too quickly. These drugs can be administered topically, orally, or through injection. Commonly used Dry Eye Drugs include artificial tears, anti-inflammatory medications, and immunomodulators.
Some companies in the Dry Eye Drug market include Allergan, Bausch + Lomb, Santen Pharmaceuticals, Shire, and Sun Pharmaceuticals. Show Less Read more